Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 940 | 704 | 714 | 597 | N/A |
| Marketable Securities | 61,298 | 17,460 | 38,467 | 42,774 | N/A |
| Receivables | 61,287 | 549 | 1,596 | 974 | N/A |
| Inventories | N/A | N/A | 1,892 | 101 | N/A |
| Other current assets | 3,223 | 8,445 | 966 | 266 | 0 |
| TOTAL | $128,808 | $28,741 | $43,635 | $44,712 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 394 | 2,020 | 3,942 | 3,792 | N/A |
| Other Non-Current Assets | 8,265 | 6,280 | 1,591 | 2,510 | 0 |
| TOTAL | $8,659 | $8,300 | $5,533 | $6,302 | $N/A |
| Total Assets | $137,467 | $37,041 | $49,168 | $51,014 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,513 | 11,535 | 8,339 | 4,565 | 0 |
| TOTAL | $58,209 | $21,494 | $10,469 | $6,609 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,200 | 25,000 | 47,411 | N/A |
| Deferred Revenues | 40,471 | N/A | 952 | 952 | N/A |
| Other Non-Current Liabilities | 3 | 11 | 1,120 | 67,283 | 0 |
| TOTAL | $84,278 | $1,211 | $27,412 | $118,067 | $N/A |
| Total Liabilities | $142,487 | $22,705 | $37,881 | $124,676 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,709 | 31,653 | 27,429 | N/A | N/A |
| Common Shares | 33 | 32 | 27 | 9 | N/A |
| Retained earnings | -274,916 | -241,424 | -187,503 | -142,544 | N/A |
| Other shareholders' equity | 33 | 0 | 0 | 32,746 | 0 |
| TOTAL | $-5,020 | $14,336 | $11,287 | $-73,662 | $N/A |
| Total Liabilities And Equity | $137,467 | $37,041 | $49,168 | $51,014 | $0 |